Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2024) 101 OP05-01 | DOI: 10.1530/endoabs.101.OP-05-01

ETA2024 Oral Presentations Oral Session 5: Thyroid dysfunction-1 (7 abstracts)

A novel point of care device accurately and rapidely measures thyrotropin in capillary blood

George Kahaly 1 , Johannes Lotz 2 & Jan Wolf 1


1Johannes Gutenberg University (Jgu) Medical Center, Department of Medicine I, Molecular Thyroid Lab, Mainz, Germany; 2Johannes Gutenberg University (Jgu) Medical Center, Institute for Clinical Chemistry and Laboratory Medicine, Mainz


Objective: Point-of-care (POC) technologies, where the sample collection and biomarker measurement are undertaken immediately can reduce turnaround times for such measurements to a period of minutes and facilitate prompt diagnosis of e.g. thyroid dysfunction. This streamlined process is especially useful in the primary care setting, and in resource-poor environments such as developing countries, where recalling patients to receive their diagnosis can be challenging. To realize this potential, POC systems must perform to a level consistent with corresponding central lab-based systems. We have prospectively evaluated the analytical performance and clinical utility of a new, rapid POC thyrotropin (TSH) assay (Wondfo).

Methods: TSH concentration was measured in serum, whole blood and capillary blood using Wondfo or with two automated reference analyser platforms (serum only, Abbott TSH Alinity I and Roche Cobas e411). For Wondfo, 75 µl of the drawn blood sample are required, which are transferred on the test stripe for a 15-minute incubation, only. TSH levels are shown by the signal intensity of fluorescence-labelled detector antibodies.

Results: Seven hundred thirty consecutive, unselected outpatients (median age 46 years, 572 women) with various autoimmune and non-autoimmune thyroid diseases were included. Three hundred eighty-two subjects, 218, and 130 were euthyroid, hypothyroid, and hyperthyroid, respectively. TSH measurements were user-independent. Linearity was very good and recovery rate was 97–127%. When measured simultaneously in two POC Wondfo devices, the slope of the regression line was 1.03 (serum) and 1.02 (blood), with Spearman’s correlation of 0.99 for both. Total intra-and inter-assay variation [CV%] was 12.1% and 16.2%, respectively. Total CV% was 10.6-22.6% and 14.5-21.6% in serum and whole blood, respectively. TSH measurements between the POC assay and the reference analysers correlated strongly (r = 0.93–0.96). There was no relevant influence of the user-performance on the POC device. The CVs were 13% and 17% in serum and potassium-EDTA whole blood, respectively, and were within the range expected from the overall CVs of the POC device. Prolongation of incubation time increased TSH results of 12% (13%) and 33% (35%) after two and five additional minutes in serum (blood), respectively. Total haemolysis, but not elevated bilirubin or lipemia, disrupted TSH measurement.

Conclusions: For the first time, a POC system, which accurately measures TSH from three commonly used matrices is introduced. This rapid POC device was straightforward to use without need for specialist technicians and demonstrated user-independent analytic performance very suitable for clinical diagnosis and differential diagnosis of thyroid dysfunction.

Volume 101

46th Annual Meeting of the European Thyroid Association (ETA) 2024

European Thyroid Association 

Browse other volumes

Article tools

My recent searches

No recent searches.